Hydrocortisone Butyrate 0.1% Cream

DRUG3 trials

Sponsors

DS Biopharma, MC2 Therapeutics, Peking Union Medical College Hospital

Conditions

Atopic DermatitisGranulomatous MastitisVasoconstriction

Phase 1

Evaluation of the Vasoconstriction Properties of MC2-01 Cream

CompletedNCT03758365

MC2 TherapeuticsVasoconstriction

Start: 2018-11-05End: 2018-11-23Updated: 2020-01-09

Phase 2

Efficacy and Steroid Sparing Potential Study of DGLA Cream in Early Childhood Patients With Moderate to Severe Atopic Dermatitis

CompletedNCT03676933

DS BiopharmaAtopic Dermatitis

Start: 2015-10-31End: 2016-04-25Updated: 2019-02-08

Phase 4

Local Steroid Treatment for Idiopathic Granulomatous Mastitis (LSTIGM)

Peking Union Medical College HospitalGranulomatous Mastitis

Start: 2019-02-19End: 2022-01-31Target: 100Updated: 2020-12-03